Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miao Mo

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
Journal of Surgical Oncology|August 11, 2025
Evolving Trends in Postmastectomy Breast Reconstruction With Autologous Tissues: A Large-Scale, 24-Year Retrospective Study in ChinaXuliren Wang, Zhibo Shao, Han Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 6, 2023
S100A5 Attenuates Efficiency of Anti-PD-L1/PD-1 Immunotherapy by Inhibiting CD8<sup>+</sup> T Cell-Mediated Anti-Cancer Immunity in Bladder CarcinomaHuihuang Li, Jinbo Chen, Zhenghao Li, et al.
Clinical and Translational Radiation Oncology|November 12, 2024
Post-mastectomy hypofractionated versus conventionally fractionated radiation therapy for patients receiving immediate breast reconstruction: Subgroup analysis of a phase III randomized trialXiaomeng Zhang, Xiaofang Wang, Yajuan Chu, et al.
European Urology Oncology|July 2, 2022
Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer: A Phase II Randomized Controlled TrialBo Dai, Sheng Zhang, Fang-Ning Wan, et al.
International Journal of Radiation Oncology, Biology, Physics|December 26, 2025
A prospective phase II trial of hypofractionated stereotactic radiotherapy (FSRT) for patients with 1-10 brain metastases from breast cancerJin Meng, Li Zhang, Jingyao Chen, et al.
Radiation Oncology (London, England)|July 1, 2023
Favorable prognosis of breast cancer brain metastases patients with limited intracranial and extracranial metastatic lesionsWei Shi, Yang Li, Hua Sun, et al.
Gland Surgery|November 4, 2021
Delayed initiation of radiation therapy is associated with inferior outcomes for breast cancer patients with hormone receptor-negative tumors after breast-conserving surgeryXiaoyan Ma, Jie Chen, Ding Ma, et al.
Scientific Reports|January 31, 2025
Hypofractionated partial breast irradiation after breast-conserving surgery for patients with early stage breast cancer in China Mainland: a single-arm prospective trialXiaomeng Zhang, Xiaofang Wang, Zhuohua Xu, et al.
Pathology, Research and Practice|January 9, 2022
The clinical significance of transcription factor WD repeat and HMG-box DNA binding protein 1 in laryngeal squamous cell carcinoma and its potential molecular mechanismJi-Yun Wu, Xiao-Lu Lan, Dong-Mei Yan, et al.
FEBS Open Bio|November 8, 2022
WDHD1 is over-expressed in nasopharyngeal carcinoma and may control the expression of ITGAVJi-Yun Wu, Yi-Tong Niu, Su-Ning Huang, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Journal of Surgical Oncology|August 11, 2025
Evolving Trends in Postmastectomy Breast Reconstruction With Autologous Tissues: A Large-Scale, 24-Year Retrospective Study in ChinaXuliren Wang, Zhibo Shao, Han Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 6, 2023
S100A5 Attenuates Efficiency of Anti-PD-L1/PD-1 Immunotherapy by Inhibiting CD8<sup>+</sup> T Cell-Mediated Anti-Cancer Immunity in Bladder CarcinomaHuihuang Li, Jinbo Chen, Zhenghao Li, et al.
Clinical and Translational Radiation Oncology|November 12, 2024
Post-mastectomy hypofractionated versus conventionally fractionated radiation therapy for patients receiving immediate breast reconstruction: Subgroup analysis of a phase III randomized trialXiaomeng Zhang, Xiaofang Wang, Yajuan Chu, et al.
European Urology Oncology|July 2, 2022
Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer: A Phase II Randomized Controlled TrialBo Dai, Sheng Zhang, Fang-Ning Wan, et al.
International Journal of Radiation Oncology, Biology, Physics|December 26, 2025
A prospective phase II trial of hypofractionated stereotactic radiotherapy (FSRT) for patients with 1-10 brain metastases from breast cancerJin Meng, Li Zhang, Jingyao Chen, et al.
Radiation Oncology (London, England)|July 1, 2023
Favorable prognosis of breast cancer brain metastases patients with limited intracranial and extracranial metastatic lesionsWei Shi, Yang Li, Hua Sun, et al.
Gland Surgery|November 4, 2021
Delayed initiation of radiation therapy is associated with inferior outcomes for breast cancer patients with hormone receptor-negative tumors after breast-conserving surgeryXiaoyan Ma, Jie Chen, Ding Ma, et al.
Scientific Reports|January 31, 2025
Hypofractionated partial breast irradiation after breast-conserving surgery for patients with early stage breast cancer in China Mainland: a single-arm prospective trialXiaomeng Zhang, Xiaofang Wang, Zhuohua Xu, et al.
Pathology, Research and Practice|January 9, 2022
The clinical significance of transcription factor WD repeat and HMG-box DNA binding protein 1 in laryngeal squamous cell carcinoma and its potential molecular mechanismJi-Yun Wu, Xiao-Lu Lan, Dong-Mei Yan, et al.
FEBS Open Bio|November 8, 2022
WDHD1 is over-expressed in nasopharyngeal carcinoma and may control the expression of ITGAVJi-Yun Wu, Yi-Tong Niu, Su-Ning Huang, et al.
Pageof 13